South San Francisco, California 94080, United States
Founders & Team
Thomas Rando, Joseph Rodgers
Number of employees
Total funding ($M)
Altered intercellular communication
small molecule drugs
Fountain Therapeutics is building a pipeline of therapeutics to treat age-related diseases by reversing cellular age. The company has combined the expertise of leaders in aging research and computation to build an AI-driven platform that extracts previously hidden cellular features to measure aging with remarkable precision. Fountain is currently screening a large diversity of drug compounds, including small molecules and biologics, to identify novel drugs that specifically reverse the age of cells for the development of therapeutics to treat age-related diseases.